BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29343447)

  • 1. Altered B lymphocyte homeostasis and functions in systemic sclerosis.
    Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S
    Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis.
    Simon D; Balogh P; Bognár A; Kellermayer Z; Engelmann P; Németh P; Farkas N; Minier T; Lóránd V; Czirják L; Berki T
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):30-36. PubMed ID: 27056741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
    Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
    Front Immunol; 2021; 12():686483. PubMed ID: 34276673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
    Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
    Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.
    Mavropoulos A; Simopoulou T; Varna A; Liaskos C; Katsiari CG; Bogdanos DP; Sakkas LI
    Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression levels of FcγRIIB on naïve and double-negative memory B cells in patients with systemic sclerosis.
    Yagi-Numata N; Matsushita T; Takehara K; Hamaguchi Y
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):23-31. PubMed ID: 30719970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis.
    Taher TE; Ong VH; Bystrom J; Hillion S; Simon Q; Denton CP; Pers JO; Abraham DJ; Mageed RA
    Arthritis Rheumatol; 2018 Mar; 70(3):450-461. PubMed ID: 29193892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
    Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
    Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
    Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
    Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
    Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
    Front Immunol; 2018; 9():753. PubMed ID: 29706966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.
    Yoshizaki A; Taniguchi T; Saigusa R; Fukasawa T; Ebata S; Numajiri H; Nakamura K; Yamashita T; Takahashi T; Toyama T; Asano Y; Tedder TF; Sato S
    Ann Rheum Dis; 2016 Oct; 75(10):1858-65. PubMed ID: 26567180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subset-specific alterations in frequencies and functional signatures of γδ T cells in systemic sclerosis patients.
    Henriques A; Silva C; Santiago M; Henriques MJ; Martinho A; Trindade H; da Silva JA; Silva-Santos B; Paiva A
    Inflamm Res; 2016 Dec; 65(12):985-994. PubMed ID: 27576328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity.
    Matsushita T; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    Rheumatology (Oxford); 2016 Feb; 55(2):263-7. PubMed ID: 26350483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a novel CD30
    Higashioka K; Kikushige Y; Ayano M; Kimoto Y; Mitoma H; Kikukawa M; Akahoshi M; Arinobu Y; Horiuchi T; Akashi K; Niiro H
    Clin Exp Immunol; 2020 Sep; 201(3):233-243. PubMed ID: 32538493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
    Okada Y; Ochi H; Fujii C; Hashi Y; Hamatani M; Ashida S; Kawamura K; Kusaka H; Matsumoto S; Nakagawa M; Mizuno T; Takahashi R; Kondo T
    J Autoimmun; 2018 Mar; 88():103-113. PubMed ID: 29146546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells.
    Kuwana M; Medsger TA; Wright TM
    J Immunol; 2000 Jun; 164(12):6138-46. PubMed ID: 10843663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.